Matt Zuga insider trades

Open-market stock purchases and sales by Matt Zuga, CFO & Chief Business Officer at Acumen Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 8, 2019.

Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -92%.

Recent trades

DateStockTradeValue
Jan 22, 2026ABOS Acumen Pharmaceuticals, IncSold$3.1K
Jan 21, 2026ABOS Acumen Pharmaceuticals, IncSold$4.5K
Jan 16, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Jan 16, 2026ABOS Acumen Pharmaceuticals, IncBought (not open market)—
Jan 8, 2026ABOS Acumen Pharmaceuticals, IncSold$12.5K
Jan 7, 2026ABOS Acumen Pharmaceuticals, IncSold$8.2K
Jan 7, 2026ABOS Acumen Pharmaceuticals, IncSold$3.4K
Jan 6, 2026ABOS Acumen Pharmaceuticals, IncSold$10K
Jan 5, 2026ABOS Acumen Pharmaceuticals, IncSold$7.8K

Companies traded

  • ABOS Acumen Pharmaceuticals, Inc: 11 sales, last Jan 22, 2026
  • ELUT Elutia Inc: other filings, last May 29, 2025
  • TELA TELA Bio, Inc: 2 buys, last Nov 13, 2019

Get free alerts when Matt Zuga files a new trade →